Announced
Completed
Financials
Tags
Private
Completed
Friendly
Single Bidder
United States
infection prevention
wound care
Medical Supplies
Acquisition
Domestic
Majority
Private Equity
Synopsis
Mountaingate Capital-backed BioDerm, a manufacturer of proprietary hydrocolloid products, completed the acquisition of Argentum Medical, a provider of infection prevention solutions and wound care products, from Shore Capital Partners, a Chicago-based private equity firm. Financial terms were not disclosed. "Shore Capital is immensely proud of what Raul and the management team built. We are excited for Argentum to continue providing significant value to the healthcare system as an international industry leader in infection prevention management," Don Pierce, Shore Partner.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.